ArticleCureus2026
Sequential Esophageal Squamous Cell Carcinoma and Small Cell Carcinoma Following Prior Nissen Fundoplication.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary small cell carcinoma of the esophagus (PSCCE) is a rare and aggressive malignancy with clinical features that often resemble more common esophageal cancers, leading to delayed diagnosis and uncertainty in management. We present a unique case of sequential squamous cell carcinoma followed by PSCCE in the distal esophagus after a previous Nissen fundoplication, emphasizing diagnostic and surveillance challenges. A 63-year-old man with a history of gastroesophageal reflux disease (GERD) and prior fundoplication presented with chest pain and progressive dysphagia. Initial esophagogastroduodenoscopy (EGD) revealed a distal esophageal lesion, and biopsy confirmed invasive squamous cell carcinoma arising from Barrett's mucosa, which was treated with endoscopic mucosal resection. One month later, the patient underwent endoscopic ultrasound (EUS) and endoscopic mucosal resection (EMR); the resection specimen showed squamous cell carcinoma in situ without residual invasive carcinoma and had negative margins. Four months after resection, surveillance endoscopy identified a new friable nodular mass in the distal esophagus. Histopathologic evaluation revealed poorly differentiated small cell carcinoma with a high proliferative index, positive staining for synaptophysin and CAM 5.2, and negative staining for chromogranin and CD45. Staging evaluation revealed no evidence of distant metastases. This report illustrates the rare occurrence of metachronous esophageal cancers with distinct histologic subtypes arising within a short time interval. The rapid development of a second malignancy suggests multifactorial carcinogenesis, including chronic mucosal injury and previous surgical alterations. Given the aggressive nature of PSCCE and the limited evidence available to guide treatment, close surveillance following endoscopic resection of esophageal malignancies is essential, particularly in patients with underlying esophageal pathology. Further studies are needed to better define risk factors and optimal management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.